RxDoctor Payments Data

Carol Berg, MD

General Practice · Cookeville, TNNPI 1184649246

Payments from drug & device makers

$1,973in general payments, 2019–2025

Across 109 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$578
  • Lilly USA, LLC$249
  • AstraZeneca$138
  • Pfizer$130
  • GSK$126
  • Boehringer Ingelheim$113
  • plus $639 from 15 others

What the payments were for

  • Food & beverage$1,973100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,973 in reported general payments places this provider in the 85th percentile of 1,632 general practice providers in Tennessee.

See all general practice providers in Tennessee

Medicare billing

Part B allowed, 2024
$154,779
Medicare patients
219
Services billed
6,168

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RybelsusSemaglutide50$78,111
EliquisApixaban53$75,813
OzempicSemaglutide62$74,585
MounjaroTirzepatide49$61,326
JardianceEmpagliflozin55$49,316
XareltoRivaroxaban33$35,538
FarxigaDapagliflozin Propanediol19$21,610
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$15,761
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$7,511
Rosuvastatin Calcium351$5,540
Losartan Potassium355$4,860
SynthroidLevothyroxine Sodium54$4,277
Levothyroxine Sodium370$3,780
Atorvastatin Calcium260$3,280
Omeprazole218$3,255

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$578$152,696112 claims
PfizerEliquis$130$75,81353 claims
Lilly USA, LLCMounjaro$249$61,32649 claims
Boehringer IngelheimJardiance$113$49,31655 claims
AstraZenecaFarxiga$138$21,61019 claims
GSKTrelegy Ellipta$126$15,76112 claims
AbbVieSynthroid$78$4,27754 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,632 general practice providers in Tennessee.

Other general practice in Cookeville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →